Skip to Main Content

Author Details

Jessica A Plante
2014
61
27
PMIDPaper TitleJournal TitlePublished Year
36722972SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.J Virol2023
37846978Complete genome sequence of Koutango virus strain DakAnD5443 isolated from in 1968.2023
37896967Vaccination against SARS-CoV-2 Does Not Protect against the Development of Anosmia in a Hamster Model.Vaccines (Basel)2023
37693415SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infection.bioRxiv2023
37460536Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters.Nat Commun2023
37131784Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection.bioRxiv2023
36680235Morphologic and Genetic Characterization of Ilheus Virus, a Potential Emergent Flavivirus in the Americas.Viruses2023
37425880Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication.bioRxiv2023
34818667The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.Nature2022
36103514Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models.Sci Transl Med2022
36229471Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.Nat Commun2022
35896528A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.Nat Commun2022
36013996Yellow Fever: Roles of Animal Models and Arthropod Vector Studies in Understanding Epidemic Emergence.Microorganisms2022
35881779QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.Proc Natl Acad Sci U S A2022
36146877Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.Viruses2022
36203546SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3.bioRxiv2022
35926067An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif.Sci Immunol2022
35728038Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.PLoS Pathog2022
33736732Outbreak of coronavirus disease 2019 (COVID-19) among operating room staff of a tertiary referral center: An epidemiologic and environmental investigation.Infect Control Hosp Epidemiol2022
34671771Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.bioRxiv2022
34749526Lineage Divergence and Vector-Specific Adaptation Have Driven Chikungunya Virus onto Multiple Adaptive Landscapes.mBio2021
33494095Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.Nature2021
33691138A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.Cell2021
33789086The variant gambit: COVID-19's next move.Cell Host Microbe2021
33721754Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.Biomed Pharmacother2021
33873199Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.Nature2021
33501436A <i>trans</i> -complementation system for SARS-CoV-2.bioRxiv2021
34358022Characterization of a Dengue Virus Serotype 1 Isolated from a Patient in Ciudad Juarez, Mexico.Pathogens2021
34131306Author Correction: Spike mutation D614G alters SARS-CoV-2 fitness.Nature2021
33758846Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.bioRxiv2021
33758836The N501Y spike substitution enhances SARS-CoV-2 transmission.bioRxiv2021
33594366Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates.bioRxiv2021
33171111Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques.Am J Pathol2021
33106671Spike mutation D614G alters SARS-CoV-2 fitness.Nature2021
34929014The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease.PLoS Pathog2021
34581669Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.Elife2021
34735434Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.PLoS Biol2021
32661400Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.Nat Med2020
32160149Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.Emerg Infect Dis2020
32935091Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility.Res Sq2020
32699848Prophylactic and Therapeutic Inhibition of In Vitro SARS-CoV-2 Replication by Oleandrin.bioRxiv2020
32869021Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis.bioRxiv2020
32908978Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility.bioRxiv2020
32568661Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions.Emerg Infect Dis2020
32511316Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient.bioRxiv2020
31462558Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity.J Virol2019
31053842Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates.J Infect Dis2019
29800370Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate.J Infect Dis2018
30115888Colonized <i>Sabethes cyaneus</i>, a Sylvatic New World Mosquito Species, Shows a Low Vector Competence for Zika Virus Relative to <i>Aedes aegypti</i>.Viruses2018
30469417ZIKV Demonstrates Minimal Pathologic Effects and Mosquito Infectivity in Viremic Cynomolgus Macaques.Viruses2018
  • 1 - 50 of 61

Recommended Authors

Collaborators

University of Texas Medical Branch
Co-authored papers 45
University of Texas Medical Branch
Co-authored papers 33
University of Texas Medical Branch
Co-authored papers 17
University of Texas Medical Branch
Co-authored papers 16
Zhengzhou University
Co-authored papers 8
University of Texas Medical Branch
Co-authored papers 8
University of North Carolina
Co-authored papers 8
University of Texas Medical Branch
Co-authored papers 8
University of North Carolina at Chapel Hill
Co-authored papers 6
University of Texas Medical Branch
Co-authored papers 6
Co-authored papers 5
University of North Carolina at Chapel Hill
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
National Center for Toxicological Research
Co-authored papers 4
Co-authored papers 4
University of North Carolina
Co-authored papers 4
Co-authored papers 4
Institute for Human Infection and Immunity, University of Texas Medical Branch
Co-authored papers 3
Co-authored papers 3
Houston Methodist Research Institute
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2